Bayer | BAYN - Des Atouts





Des Atouts Changement Date
Air Liquide EUR 56.28B 4.36B 2026-06
Akzo Nobel EUR 16.13B 647M 2026-06
Alcon AG USD 31.1B 521M 2026-06
Amarin USD 624.36M 21.4M 2026-06
Arkema EUR 14.17B 48.4M 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
BASF EUR 83.87B 2.1B 2026-06
Bayer EUR 107.29B 659M 2026-06
Beiersdorf EUR 12.76B 166M 2025-12
Corteva USD 41.64B 1.08B 2026-06
Covestro EUR 13.47B 245M 2025-12
Essilor EUR 65.06B 1.16B 2026-06
Fresenius EUR 41.84B 526M 2026-06
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
Genmab DKK 12.52B 139M 2026-06
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
GRIFOLS EUR 20.09B 12M 2026-06
Henkel EUR 36.5B 3.96B 2026-06
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Johnson Matthey GBP 5.97B 142M 2026-06
Linde USD 86.32B 502M 2026-03
Lonza CHF 18.97B 164M 2025-12
Merck EUR 52.69B 383M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Nutrien USD 53.56B 368M 2026-06
Philips EUR 26.7B 565M 2026-06
PPG Industries USD 22.53B 384M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
SAP EUR 75.61B 2.15B 2026-06
Solvay EUR 6.08B 122M 2026-06
UCB EUR 18.16B 971M 2025-12
Umicore EUR 10.06B 603.5M 2026-06
Vinci EUR 134.87B 1.8B 2026-06